Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04065711 · ClinicalTrials.gov registry record · NA
Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite
A NA study, sponsored by Soliton.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT04065711 is a NA study that has completed, run by Soliton. The registered enrollment target is 67 participants.
The verdict
NCT04065711, a NA study, has completed, sponsored by Soliton.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
To evaluate the safety, and efficacy of Soliton's Rapid Acoustic Pulse (RAP) device for the temporary improvement in the appearance of cellulite.
Interventions
- DEVICE Soliton's Rapid Acoustic Pulse (RAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2019-07-20 |
| Est. Completion | 2021-08-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04065711
The ClinicalTrials.gov registry entry for NCT04065711 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Soliton, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Soliton's Rapid Acoustic Pulse (RAP) is the first listed.
NCT04065711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04065711 about?
NCT04065711 is a clinical study titled "Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite". To evaluate the safety, and efficacy of Soliton's Rapid Acoustic Pulse (RAP) device for the temporary improvement in the appearance of cellulite.
What is the current status of trial NCT04065711?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2019-07-20. Estimated completion is 2021-08-26.
What interventions are being tested in trial NCT04065711?
The interventions under investigation include: Soliton's Rapid Acoustic Pulse (RAP) (DEVICE).
Who is sponsoring clinical trial NCT04065711?
This trial is sponsored by Soliton, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.